PharmaDrug is restructuring approximately $1 million in debt in the form of convertible debentures.
Psychedelics
Osoyoos Provides Corporate Update on AI Pharma Acquisition
Osoyoos Cannabis provides additional details on its previously announced acquisition.
Psychedelics Investing 101: the Drug Approval Process and Drug Patents
Understanding the drug approval process that leads to drug patents and drug licensing is of critical importance for successful investing in psychedelics.
Mydecine Innovations Group Adds 7-Time Nobel Peace Prize Nominee Dr. M.S Reddy to Its Scientific Advisory Board
Mydecine's new Scientific Advisor holds over 150 U.S. and international patents and will oversee Mydecine's mycology lab.
IntelGenx and Cybin Corp Enter Into Feasibility Agreement for Fast-Acting, Orally-Dissolving Psilocybin Film
Cybin Corp is partnering with IntelGenx Corp to produce a new delivery system for pharmaceutical-grade psilocybin.
Mydecine Adds Biotech Heavy-Hitter To Science Team
Mydecine Innovations Group has added one of the world's pre-eminent biotech scientists to its Scientific Advisory Board.
The Psychedelics Revolution: From ‘War on Drugs’ To Funding Psychedelic Drug Research
The Psychedelics Revolution. One part changing social attitudes. One part medical necessity. One part hard economics.
CannaGlobal, Sansero Life Sciences and Rise Wellness To Merge, Creating a New International Psychedelics Company
Three private companies are merging to create a new entity in the psychedelics space.
Hinterland to Acquire Novamind Ventures Inc
Novamind Ventures Inc. is preparing to go public via amalgamation with unlisted public company, Hinterland Metals Inc.
Red Light Holland Names Medical and Scientific Division
Red Light Holland makes move into medicinal psychedelic applications.
Hollister Biosciences Inc. Announces Private Placement Financing of Up to $1.5 Million
Hollister Biosciences announces a private placement for CAD$1.5 million, expected to close by July 12, 2020.
MPV Exploration Inc. Announces Definitive Agreement for Amalgamation with Entheon Biomedical Corp and Financing
Entheon Biomedical announces a three-cornered amalgamation with MPV Exploration along with concurrent financing.
Field Trip Psychedelics Inc. Launches Field Trip Basecamp for combat veterans, first responders and healthcare workers
Field Trip announces a new therapeutic program as the company prepares for its coming RTO.
Psychedelics: A Better Way To Treat Depression
Psychedelic drugs represent a potentially enormous step forward in treating an epidemic for which there are currently no good treatment options.
What Does Field Trip Psychedelics Offer Investors?
Field Trip Psychedelics has just announced a letter of intent to go public via RTO.